Lisa Zaba, MD, PhD

The Skin Cancer Program in San Jose is dedicated to addressing the dermatologic needs of cancer patients, operating within the Cancer Center South Bay. This clinic is designed to provide timely and efficient access for patients experiencing skin conditions related to cancer treatment, ensuring prompt recognition and management of these complications to enhance quality of life. As part of the nationally recognized Stanford Comprehensive Cancer Network, the Skin Cancer Program emphasizes urgent and same-day visits to accommodate patients' needs. The clinic collaborates closely with various oncology specialty clinics, reinforcing its commitment to comprehensive care for those undergoing cancer diagnosis and treatment. Generated from the website

The Stanford Pigmented Lesion and Melanoma Clinic provides precision care for people diagnosed with cutaneous (skin) and metastatic melanoma (melanoma that has spread). We also deliver initial evaluation and coordinated treatment for those at increased risk of melanoma based on mole pattern and family history. Our team of melanoma experts works closely together to provide a thorough evaluation and individualized care plan that meets your needs and goals. You have access to the latest breakthroughs in melanoma therapy, including genetic assessment. The Stanford Pigmented Lesion and Melanoma Program offers two locations for comprehensive care for melanoma, abnormal moles, and other skin cancers.

Lisa Zaba M.D. Ph.D., is an Associate Professor of Dermatology, and Director of the Merkel cell carcinoma (MCC) multi-disciplinary clinic and member of the supportive oncodermatology group at the Stanford Cancer Center. She runs a lab focusing on the immunology of MCC and the treatment and prognostic implications of immune checkpoint inhibitor and targeted therapy rashes. Dr. Zaba completed medical school at Cornell University, PhD in immunology at Rockefeller University, Residency and Post-Doc at Stanford University in 2013.